GlassScriptPhysician profile
Kenaz Bakdash
NPI 1881122273
$4,707.17
in general payments reported to CMS, 2019-2025
13 companies · $2,365 in 2025
The $2,365 reported for 2025 was more than what 91% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $763 · 2023: $656 · 2024: $923 · 2025: $2,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,944.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,216.02 | 2024-2025 | Clottriever Bold Catheter, Flowtriever, Flowtriever Catheter, S |
| Boston Scientific Corporation | $600.23 | 2022-2023 | Embold Fibered, Fathom -16, Angiojet Ultra 5000a |
| Inari Medical, INC. | $541.06 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Histosonics, INC. | $280.71 | 2024 | |
| Medtronic, INC. | $277.57 | 2022-2025 | Solitaire X |
| Imperative Care, INC | $210.77 | 2025 | Symphony Catheter |
| Angiodynamics, INC. | $184.24 | 2022 | |
| Terumo Medical Corporation | $155.03 | 2022-2024 | Azur Cx Detachable |
| Penumbra, INC. | $127.34 | 2023 | Smart Coil |
| Trisalus Life Sciences, INC. | $34.78 | 2022 | |
| Avanos Medical | $31.82 | 2024-2025 | Coolief Cooled Radiofrequency, Generator |
| Abbott Laboratories | $24.01 | 2025 | Perclose Prostyle |
| Abiomed | $23.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenaz Bakdash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.